Tesamorelin is a peptide from the growth-hormone pathway family, and especially interesting because of the context in which it has been studied — visceral fat. We'll explain.
The information in this article is for educational purposes only and does not constitute medical advice. All products on the site are for research use only.
What is Tesamorelin?
Tesamorelin is an analog of GHRH — the hormone that releases growth hormone — similar to the family of CJC-1295. It has been studied in research in the context of the growth-hormone axis, and uniquely also in the context of visceral fat (the deep fat around the organs).
What is special about it?
Unlike most peptides in this category, Tesamorelin has a broader clinical history, and it has even been approved for medical use in a very specific indication (fat accumulation in HIV patients). This makes it one of the more established, well-studied members of the family — but the product on the site is for research use only.
What does the research examine?
The research interest focuses on the effect on the GH/IGF-1 axis and on visceral fat tissue. As always, there is a difference between an approved clinical indication and research use, and no sweeping conclusions should be drawn.
Frequently asked questions
How is it different from CJC-1295?
Both are analogs of GHRH, but Tesamorelin has been studied more in the context of visceral fat. See What is CJC-1295.
How is it reconstituted?
From powder, using bacteriostatic water andour dilution calculator.
For the research product details: Tesamorelin. For the general guide — What are peptides.
Before buying, it's worth going over theA guide to choosing a peptide supplier .
The information is general and for educational purposes only and does not constitute medical advice. The products are for research use only.
